Blue Trust Inc
CORT icon

Blue Trust Inc’s Corcept Therapeutics CORT Stock Holding History

Blue Trust Inc’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.2K Sell
132
-287
-68% -$30.9K ﹤0.01% 1591
2026
Q2 		$36.4K Sell
419
-71
-14% -$4.29K ﹤0.01% 1476
2026
Q1 		$19.8K Sell
490
-584
-54% -$21.8K ﹤0.01% 1648
2025
Q4 		$37.4K Sell
1,074
-424
-28% -$33.3K ﹤0.01% 1460
2025
Q3 		$124K Buy
1,498
+43
+3% +$3.11K ﹤0.01% 980
2025
Q2 		$107K Sell
1,455
-890
-38% -$64.5K ﹤0.01% 1021
2025
Q1 		$268K Sell
2,345
-585
-20% -$35.6K ﹤0.01% 607
2024
Q4 		$148K Sell
2,930
-8,728
-75% -$457K ﹤0.01% 764
2024
Q3 		$379K Buy
11,658
+8,132
+231% +$289K ﹤0.01% 573
2024
Q2 		$88.8K Buy
3,526
+1,962
+125% +$53.7K ﹤0.01% 1025
2024
Q1 		$39.4K Buy
1,564
+1,177
+304% +$27.8K ﹤0.01% 993
2023
Q4 		$11K Buy
+387
New +$10.6K ﹤0.01% 1540
2023
Q3 		– Sell
-40
Closed -$1K – 2075
2023
Q2 		$1K Hold
40
– – ﹤0.01% 1822
2023
Q1 		$1K Buy
40
+10
+33% +$219 ﹤0.01% 2126
2022
Q4 		$1K Buy
+30
New +$752 ﹤0.01% 2031

Other funds holding CORT

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Brown Capital Management
Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

Blue Trust Inc's CORT Position: Q3 2026 in Review

Blue Trust Inc reduced its Corcept Therapeutics (CORT) stake by 68% in Q3 2026, selling an estimated $30.9K and leaving 132 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Blue Trust Inc first reported a position in CORT in Q4 2022 and has held it in 15 quarters since. The position peaked at $379K in Q3 2024. 118 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Blue Trust Inc held 132 shares of Corcept Therapeutics worth $15.2K as of Q3 2026.
  • Blue Trust Inc sold 287 Corcept Therapeutics shares in Q3 2026, an estimated $30.9K.
  • Corcept Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #1591 holding.
  • Blue Trust Inc first reported a position in Corcept Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • Blue Trust Inc's Corcept Therapeutics position peaked at $379K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.